| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.73B | 47.47B | 36.70B | 32.41B | 26.29B | 25.98B |
| Gross Profit | 39.81B | 46.33B | 33.72B | 31.74B | 23.10B | 22.71B |
| EBITDA | 14.12B | 20.14B | 9.90B | 7.05B | 5.93B | 4.58B |
| Net Income | 10.29B | 13.35B | 5.28B | 4.20B | 3.49B | 2.29B |
Balance Sheet | ||||||
| Total Assets | 1.61T | 1.59T | 1.58T | 1.49T | 1.47T | 1.43T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 80.71B | 68.64B | 74.90B | 55.07B | 75.00B |
| Total Debt | 10.08B | 19.81B | 53.18B | 23.96B | 63.41B | 61.65B |
| Total Liabilities | 1.45T | 1.44T | 1.42T | 1.36T | 1.35T | 1.31T |
| Stockholders Equity | 158.60B | 152.52B | 148.68B | 115.12B | 114.07B | 111.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.71B | 7.21B | -24.09B | -4.79B | -21.54B |
| Operating Cash Flow | 0.00 | 5.66B | 8.20B | -23.70B | -4.27B | -21.10B |
| Investing Cash Flow | 0.00 | 11.18B | -12.51B | 46.04B | -14.57B | 29.63B |
| Financing Cash Flow | 0.00 | -2.59B | -2.04B | -1.98B | -800.00M | -826.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥151.31B | 8.80 | ― | 2.63% | 23.55% | -21.15% | |
72 Outperform | ¥139.92B | 8.04 | 3.68% | 2.26% | 9.34% | 20.61% | |
72 Outperform | ¥146.72B | 7.55 | ― | 2.29% | 13.93% | 54.44% | |
71 Outperform | ¥150.92B | 7.21 | ― | 2.96% | 14.85% | 21.17% | |
69 Neutral | ¥149.17B | 9.79 | ― | 2.56% | 17.66% | 49.06% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥12.08B | 21.28 | ― | 2.68% | 5.57% | -23.26% |